0,984  0,001  CYP2C9 substrate
0,983  0,001  CYP2D6 substrate
0,984  0,002  Transcription factor NF kappa B inhibitor
0,980  0,002  CYP1A2 substrate
0,976  0,001  CYP2C19 substrate
0,968  0,001  Chemopreventive
0,956  0,001  UGT1A6 substrate
0,956  0,001  Proliferative diseases treatment
0,955  0,002  CYP3A4 substrate
0,947  0,003  Teratogen
0,944  0,003  Embryotoxic
0,933  0,005  Apoptosis agonist
0,924  0,000  Na+ K+ transporting ATPase inhibitor
0,918  0,002  Cytotoxic
0,912  0,004  Cardiotonic
0,899  0,004  Respiratory analeptic
0,897  0,005  Antineoplastic (breast cancer)
0,893  0,005  Antineoplastic (lung cancer)
0,879  0,004  Carcinogenic
0,877  0,004  Antineoplastic (ovarian cancer)
0,872  0,003  Antineoplastic (sarcoma)
0,866  0,004  Analeptic
0,866  0,005  Antineoplastic (colorectal cancer)
0,855  0,005  Antineoplastic (colon cancer)
0,843  0,002  Anesthetic general
0,829  0,005  Prostate cancer treatment
0,808  0,003  Diuretic
0,802  0,004  Antineoplastic (pancreatic cancer)
0,801  0,005  Antineoplastic (cervical cancer)
0,796  0,003  UGT1A1 substrate
0,791  0,004  DNA damaging
0,788  0,004  Antineoplastic (glioma)
0,787  0,005  Antineoplastic (non-small cell lung cancer)
0,785  0,003  Hypoxia-inducible factor 1 alpha inhibitor
0,784  0,003  Antiparasitic
0,775  0,001  ATPase inhibitor
0,772  0,002  Antihelmintic
0,766  0,005  Cytostatic
0,760  0,008  Antileukemic
0,752  0,006  Sensitization
0,747  0,004  Heart failure treatment
0,734  0,005  Antineoplastic (melanoma)
0,723  0,005  Antineoplastic (brain cancer)
0,716  0,005  NOS2 expression inhibitor
0,717  0,008  Antibacterial
0,713  0,013  TNF expression inhibitor
0,717  0,028  Antiinflammatory
0,691  0,004  Antineoplastic (renal cancer)
0,677  0,005  UDP-glucuronosyltransferase substrate
0,674  0,004  Anesthetic
0,668  0,010  Cholesterol antagonist
0,655  0,005  Antineoplastic (glioblastoma multiforme)
0,653  0,007  Immunosuppressant
0,646  0,005  Antineoplastic (lymphoma)
0,626  0,005  Antineoplastic (liver cancer)
0,615  0,005  Antineoplastic enhancer
0,616  0,009  Caspase 3 stimulant
0,605  0,010  NOS3 expression inhibitor
0,597  0,005  P-glycoprotein inhibitor
0,593  0,010  Nitric oxide antagonist
0,601  0,021  Antineoplastic (solid tumors)
0,590  0,015  Mutagenic
0,583  0,009  Antineoplastic (multiple myeloma)
0,577  0,004  Transcription factor STAT3 inhibitor
0,574  0,013  Cardioprotectant
0,563  0,012  Antifungal
0,563  0,014  Hepatic disorders treatment
0,546  0,005  Antineoplastic (squamous cell carcinoma)
0,544  0,005  Transcription factor STAT inhibitor
0,543  0,007  Antineoplastic (carcinoma)
0,540  0,022  Antihypercholesterolemic
0,494  0,010  Antihypoxic
0,491  0,006  Interferon gamma antagonist
0,482  0,008  Melanin inhibitor
0,486  0,014  ICAM1 expression inhibitor
0,464  0,005  Antidiarrheal
0,473  0,013  Antineoplastic (endocrine cancer)
0,463  0,004  Antifungal enhancer
0,452  0,004  Antineoplastic antibiotic
0,452  0,009  Contraceptive
0,471  0,033  Immunostimulant
0,455  0,027  Apoptosis antagonist
0,450  0,029  AR expression inhibitor
0,486  0,066  Caspase 9 stimulant
0,438  0,029  Antioxidant
0,429  0,023  Antipyretic
0,418  0,013  Sodium/bile acid cotransporter inhibitor
0,414  0,012  Hepatoprotectant
0,407  0,007  Interleukin 6 antagonist
0,400  0,008  Alkylator
0,389  0,005  Cholesterol synthesis inhibitor
0,392  0,015  Antiviral (Herpes)
0,382  0,010  Lipocortins synthesis antagonist
0,427  0,056  Antipruritic, allergic
0,382  0,013  UGT2B7 substrate
0,390  0,024  Antineoplastic (osteosarcoma)
0,385  0,024  DNA synthesis inhibitor
0,407  0,047  Antithrombotic
0,381  0,025  Angiogenesis stimulant
0,359  0,014  Prostate disorders treatment
0,358  0,030  Antimitotic
0,329  0,002  Glycine receptor agonist
0,372  0,046  Lipoprotein disorders treatment
0,333  0,018  Antiacne
0,353  0,043  UGT2B4 substrate
0,338  0,032  Antineoplastic (lymphocytic leukemia)
0,328  0,023  Antiviral (Influenza)
0,326  0,027  RNA-directed DNA polymerase inhibitor
0,313  0,016  Topoisomerase II inhibitor
0,343  0,046  Chemoprotective
0,338  0,044  Antiprotozoal (Leishmania)
0,312  0,021  Peptidyltransferase inhibitor
0,296  0,006  Contraceptive male
0,289  0,004  Antirickettsial
0,328  0,049  Antineoplastic (small cell lung cancer)
0,298  0,019  Neurotrophic factor enhancer
0,271  0,004  Microtubule formation inhibitor
0,276  0,013  Topoisomerase I inhibitor
0,321  0,060  Interleukin 2 agonist
0,280  0,019  Antiviral (Influenza A)
0,323  0,067  Antimycobacterial
0,304  0,048  Hypolipemic
0,252  0,016  Aldose reductase substrate
0,248  0,018  Psychosexual dysfunction treatment
0,243  0,020  Adenylate cyclase inhibitor
0,256  0,033  Antipruritic, non-allergic
0,249  0,027  Protein kinase stimulant
0,231  0,009  Growth stimulant
0,235  0,015  Antihemorrhagic
0,223  0,004  Protein 50S ribosomal subunit inhibitor
0,284  0,067  UGT1A9 substrate
0,246  0,036  Prostatic (benign) hyperplasia treatment
0,217  0,009  Antineoplastic alkaloid
0,269  0,061  Free radical scavenger
0,218  0,011  Antibiotic
0,252  0,045  VCAM1 expression inhibitor
0,223  0,020  DNA intercalator
0,214  0,012  Antineoplastic, alkylator
0,212  0,015  Cyclooxygenase 3 inhibitor
0,208  0,019  Expectorant
0,280  0,096  Bone diseases treatment
0,214  0,031  Antineoplastic (bone cancer)
0,213  0,035  Acute respiratory distress syndrome (ARDS) treatment
0,237  0,062  Antihypertriglyceridemic
0,275  0,102  Antihypertensive
0,179  0,011  Antiviral (Trachoma)
0,296  0,129  CYP2C19 inhibitor
0,225  0,059  Platelet adhesion inhibitor
0,240  0,075  Vasodilator
0,246  0,082  Interleukin agonist
0,198  0,038  Skin whitener
0,153  0,007  ATPase (Vacuolar H+) inhibitor
0,233  0,088  Hypoglycemic
0,174  0,033  Farnesoid X receptor antagonist
0,191  0,051  Acaricide
0,147  0,008  Bile acid receptor antagonist
0,257  0,118  Angiogenesis inhibitor
0,159  0,022  Topoisomerase II alpha inhibitor
0,277  0,140  Antiprotozoal
0,149  0,016  Transcription factor NF kappa B stimulant
0,183  0,050  Arachidonic acid antagonist
0,138  0,010  Glycine receptor antagonist
0,157  0,029  Ca2+-transporting ATPase inhibitor
0,228  0,105  Antiosteoporotic
0,144  0,021  Anabolic
0,182  0,060  Antihelmintic (Nematodes)
0,216  0,107  Spasmolytic
0,125  0,018  Antiprotozoal activity enhancer
0,115  0,008  Antitreponemal
0,127  0,021  Selectin antagonist
0,113  0,009  Antimycoplasmal
0,144  0,040  Antineoplastic (uterine cancer)
0,133  0,031  Hedgehog signaling inhibitor
0,185  0,085  Antiarrhythmic
0,104  0,013  Androgen agonist
0,129  0,046  Choleretic
0,116  0,034  Actinic keratosis treatment
0,089  0,007  RNA-directed RNA polymerase stimulant
0,122  0,041  Toll-Like receptor 4 antagonist
0,095  0,018  Estrogen agonist
0,113  0,037  Androgen antagonist
0,097  0,022  Prokinetic
0,144  0,069  Antifungal (Cryptococcus)
0,078  0,004  Microtubule stabilization
0,189  0,119  Tumour necrosis factor alpha release inhibitor
0,081  0,013  Lipocortins synthesis agonist
0,096  0,028  T cell inhibitor
0,119  0,055  Mucolytic
0,140  0,076  UGT2B15 substrate
0,195  0,132  Antituberculosic
0,158  0,099  Wound healing agent
0,164  0,105  Abortion inducer
0,143  0,086  UGT2B9 substrate
0,117  0,060  Estrogen antagonist
0,070  0,018  H+/K+-transporting ATPase inhibitor
0,101  0,049  ABCA1 expression enhancer
0,056  0,010  Antibiotic Aminoglycoside-like
0,066  0,021  Acetyl-CoA transferase 2 inhibitor
0,139  0,094  UGT1A4 substrate
0,070  0,026  Postmenopausal disorders treatment
0,051  0,009  Cholesterol absorption inhibitor
0,051  0,011  Glucose-6-phosphate dehydrogenase inhibitor
0,061  0,023  Antibiotic Glycopeptide-like
0,070  0,033  Hypercalcemia treatment
0,125  0,089  Lipid peroxidase inhibitor
0,148  0,117  Toxic, respiratory center
0,176  0,146  Radioprotector
0,095  0,067  Dementia treatment
0,041  0,013  HMG CoA reductase inhibitor
0,093  0,065  Vascular dementia treatment
0,107  0,079  DNA polymerase I inhibitor
0,109  0,083  Antiviral (Hepatitis B)
0,030  0,004  Antibiotic Macrolide-like
0,035  0,011  Protein 30S ribosomal subunit inhibitor
0,033  0,009  Motilin receptor agonist
0,030  0,008  GRP78 expression inhibitor
0,064  0,042  Nitric oxide donor
0,125  0,105  NOS3 expression enhancer
0,098  0,080  Protein-tyrosine phosphatase 1B inhibitor
0,043  0,026  Hypogonadism treatment
0,036  0,020  Tubulin agonist
0,094  0,080  UGT2B1 substrate
0,181  0,168  Antineoplastic (bladder cancer)
0,121  0,110  Insulin secretagoues
0,084  0,073  Thioredoxin inhibitor
0,205  0,195  Ulceration
0,092  0,082  AMP-activated protein kinase stimulant
0,076  0,067  Antispirochetal
0,135  0,128  Antineoplastic (gastric cancer)
0,032  0,025  Estrogen receptor alpha agonist
0,120  0,114  UGT1A3 substrate
0,048  0,043  Glucose-6-phosphate translocase inhibitor
0,087  0,082  Chronic obstructive bronchitis treatment
0,136  0,131  UGT2B10 substrate
0,020  0,016  Corticosteroid-like
0,016  0,013  Telomerase stimulant
0,087  0,084  UGT2B11 substrate
0,016  0,014  Progesterone agonist
0,026  0,026  Glucocorticoid antagonist

